Patheon has completed the acquisition of a state-of-the-art manufacturing facility in Florence, SC, from Roche Holdings. The company said it has begun integrating the site into the Patheon network. The site adds a 300,000 square-foot facility with manufacturing capacity for active pharmaceutical ingredient (API) ranging from development to manufacturing services. With the addition of this site, the company expands its capacity for manufacturing highly potent compounds, adds capabilities to su...